Hepcidin Level and Iron Parameters in Patients with Chronic Kidney Disease
Authors:
Open Access
- 1 January 2015
- journal article
- Published by Laboratory Medicine Online in Laboratory Medicine Online
- Vol. 5 (3) , 149-156
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Serum hepcidin-25 levels predict the progression of renal anemia in patients with non-dialysis chronic kidney diseaseNephrology Dialysis Transplantation, 2012
- Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional studyNephrology Dialysis Transplantation, 2011
- Hepcidin-25 is a Marker of the Response Rather than Resistance to Exogenous Erythropoietin in Chronic Kidney Disease/Chronic Heart Failure PatientsEuropean Journal of Heart Failure, 2010
- Hepcidin Serum Levels and Resistance to Recombinant Human Erythropoietin Therapy in Haemodialysis PatientsActa Haematologica, 2009
- Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?Nephrology Dialysis Transplantation, 2008
- Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its InternalizationScience, 2004
- Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammationBlood, 2003
- Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase proteinBlood, 2003
- A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron OverloadJournal of Biological Chemistry, 2001
- Hepcidin, a Urinary Antimicrobial Peptide Synthesized in the LiverJournal of Biological Chemistry, 2001